Your browser is no longer supported. Please, upgrade your browser.
Settings
AVDL Avadel Pharmaceuticals plc daily Stock Chart
AVDL [NASD]
Avadel Pharmaceuticals plc
Index- P/E11.17 EPS (ttm)0.92 Insider Own2.40% Shs Outstand39.85M Perf Week-0.49%
Market Cap407.67M Forward P/E41.76 EPS next Y0.25 Insider Trans6.01% Shs Float39.68M Perf Month6.56%
Income39.60M PEG- EPS next Q-0.02 Inst Own74.10% Short Float1.29% Perf Quarter-0.39%
Sales174.00M P/S2.34 EPS this Y-204.20% Inst Trans1.22% Short Ratio3.05 Perf Half Y8.48%
Book/sh1.87 P/B5.47 EPS next Y-78.82% ROA15.70% Target Price19.45 Perf Year-16.83%
Cash/sh4.36 P/C2.35 EPS next 5Y- ROE73.70% 52W Range8.14 - 12.76 Perf YTD-1.54%
Dividend- P/FCF11.42 EPS past 5Y-23.00% ROI-20.50% 52W High-19.83% Beta1.44
Dividend %- Quick Ratio2.20 Sales past 5Y35.70% Gross Margin92.00% 52W Low25.68% ATR0.37
Employees165 Current Ratio2.30 Sales Q/Q19.00% Oper. Margin39.30% RSI (14)52.85 Volatility2.50% 3.80%
OptionableYes Debt/Eq1.14 EPS Q/Q240.70% Profit Margin22.70% Rel Volume2.17 Prev Close10.17
ShortableYes LT Debt/Eq1.14 EarningsNov 08 BMO Payout0.00% Avg Volume167.15K Price10.23
Recom1.80 SMA20-1.38% SMA506.99% SMA2003.32% Volume363,327 Change0.59%
Oct-20-17 04:05PM  Avadel Pharmaceuticals to Report Third Quarter 2017 Results GlobeNewswire
Oct-19-17 04:57PM  What does Avadel Pharmaceuticals plcs (AVDL) Balance Sheet Tell Us Abouts Its Future? Simply Wall St.
Oct-05-17 07:30AM  Avadel Pharmaceuticals Announces Data Presentation for Noctiva at The American Urogynecologic Societys Annual Scientific Meeting GlobeNewswire
Oct-03-17 08:46AM  At $10.73, Is Avadel Pharmaceuticals plc (AVDL) A Buy? Simply Wall St.
Sep-13-17 07:30AM  Avadel Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
Sep-05-17 04:05PM  Avadel Pharmaceuticals Enters into Exclusive License Agreement for Noctiva GlobeNewswire
Aug-29-17 07:30AM  Avadel Pharmaceuticals to Present at the 2017 Wells Fargo Healthcare Conference GlobeNewswire
Aug-17-17 04:05PM  Avadel Pharmaceuticals Enters into Exclusive Negotiations with Serenity Pharmaceuticals for Noctiva GlobeNewswire
Aug-08-17 10:23PM  Avadel posts 2Q profit Associated Press
07:30AM  Avadel Pharmaceuticals Reports Second Quarter 2017 Results GlobeNewswire
Jul-20-17 08:30AM  Avadel Pharmaceuticals to Report Second Quarter 2017 Results GlobeNewswire
Jul-13-17 03:32PM  ETFs with exposure to Avadel Pharmaceuticals Plc : July 13, 2017 Capital Cube
Jul-03-17 02:54PM  ETFs with exposure to Avadel Pharmaceuticals Plc : July 3, 2017 Capital Cube
Jun-16-17 03:25PM  ETFs with exposure to Avadel Pharmaceuticals Plc : June 16, 2017 Capital Cube
Jun-14-17 09:48AM  Avadel Pharmaceuticals Plc :AVDL-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017 Capital Cube
May-30-17 04:03PM  Avadel Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
May-17-17 09:30AM  Avadel Pharmaceuticals Supports the Narcolepsy Network's 5th Annual DREAM BIG Walk GlobeNewswire
May-09-17 08:45AM  Investor Network: Avadel Pharmaceuticals plc to Host Earnings Call Accesswire +6.81%
07:59AM  Avadel posts 1Q profit Associated Press
07:30AM  Avadel Pharmaceuticals Reports First Quarter 2017 Results GlobeNewswire
May-03-17 03:36PM  ETFs with exposure to Avadel Pharmaceuticals Plc : May 3, 2017 Capital Cube
May-02-17 02:54PM  Avadel Pharmaceuticals Plc :AVDL-US: Earnings Analysis: Q4, 2016 By the Numbers : May 2, 2017 Capital Cube
12:24PM  Avadel Pharmaceuticals Plc :AVDL-US: Earnings Analysis: 2016 By the Numbers : May 2, 2017 Capital Cube
Apr-24-17 04:05PM  Avadel Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
Apr-17-17 04:03PM  Avadel Pharmaceuticals to Report First Quarter 2017 Results GlobeNewswire
Apr-01-17 01:04PM  AVADEL PHARMACEUTICALS PLC Financials
Mar-31-17 05:08PM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Financial Statement
Mar-30-17 04:03PM  Avadel Pharmaceuticals Announces Planned Reduction of French Workforce GlobeNewswire
Mar-28-17 05:24PM  AVADEL PHARMACEUTICALS PLC Files SEC form 10-K, Annual Report
Mar-17-17 06:03AM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -5.53%
Mar-07-17 04:08PM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Amendment or Waiver to Code of Ethics, Financial Statements and Exhibi
07:06AM  Avadel tops Street 4Q forecasts
07:00AM  Avadel Pharmaceuticals Announces $25 Million Share Repurchase Program GlobeNewswire
06:30AM  Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Results GlobeNewswire
Mar-02-17 10:01AM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Other Events
07:30AM  Avadel Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
Feb-24-17 08:30AM  Avadel Pharmaceuticals (AVDL) Looks Good: Stock Up 5.3% Zacks
Feb-16-17 06:37AM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Other Events
Feb-14-17 07:30AM  Avadel Pharmaceuticals to Report Fourth Quarter and Full Year 2016 Results GlobeNewswire
Feb-06-17 03:55PM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Other Events
07:30AM  Avadel Pharmaceuticals to Present at Two Upcoming Investor Conferences GlobeNewswire
Jan-11-17 04:05PM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Jan-06-17 01:52PM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Other Events -6.66%
Jan-05-17 11:57AM  AVADEL PHARMACEUTICALS PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits +5.18%
08:18AM  CORRECTING and REPLACING Avadel Pharmaceuticals Provides 2017 Guidance and Business Update GlobeNewswire
07:30AM  Avadel Pharmaceuticals Provides 2017 Guidance and Business Update GlobeNewswire
Jan-03-17 04:03PM  Avadel Pharmaceuticals Appoints Gregory J. Divis Chief Commercial Officer GlobeNewswire +5.39%
07:30AM  Flamel Technologies Completes Cross-Border Merger and Becomes Avadel Pharmaceuticals plc GlobeNewswire
Dec-19-16 03:38PM  FLAMEL TECHNOLOGIES SA Files SEC form 8-K, Other Events
Avadel Pharmaceuticals PLC is a pharmaceutical company engaged in drug delivery and formulation development to create safer and more efficacious pharmaceutical products.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Thornton Peter J.DirectorSep 21Buy9.745,15550,2155,155Sep 25 04:58 PM
Hatten Sandra LSee RemarksSep 14Buy9.362,10019,65437,800Sep 15 04:15 PM
Hatten Sandra LSee RemarksSep 13Buy9.355004,67335,700Sep 15 04:15 PM
THOMPSON PHILLANDAS T.See RemarksSep 13Buy9.365,00046,80063,000Sep 14 05:09 PM
STAPLETON CRAIG RDirectorSep 12Buy9.5220,000190,360110,000Sep 14 05:06 PM
DIVIS GREG JSee RemarksSep 12Buy9.3210,60098,76010,600Sep 14 05:03 PM
ANDERSON MICHAEL SChief Executive OfficerSep 12Buy9.804,00039,180229,750Sep 14 04:58 PM
Hatten Sandra LSee RemarksSep 12Buy9.151,20010,9803,400Sep 15 04:15 PM
Hatten Sandra LSee RemarksSep 12Buy9.192,20020,21835,200Sep 15 04:15 PM